To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill adds or tightens a reporting req, compliance mandate provision: 2, adds or tightens a reporting req, compliance mandate provision: 3, and creates introduces a neutral technical change provision: 4. Program for pediatric studies of drugs Section 409I(d) of the Public Health Service Act (42 U.S.C. 284m(d)) is amended to read as follows: Of the amount made. It relies on reporting requirements, compliance mandates, appropriations, and grants. The main policy areas are Healthcare.
Who Benefits and How
The available clause analysis does not identify a specific beneficiary group.
Who Bears the Burden and How
No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.
Key Provisions
- Adds or tightens a reporting req, compliance mandate provision: 2.
- Adds or tightens a reporting req, compliance mandate provision: 3.
- Creates introduces a neutral technical change provision: 4. Program for pediatric studies of drugs Section 409I(d) of the Public Health Service Act (42 U.S.C. 284m(d)) is amended to read as follows: Of the amount made...
- Creates loosens a appropriation, grant, reporting req provision: 5.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.
At a Glance
What This Bill Does
The bill adds or tightens a reporting req, compliance mandate provision: 2, adds or tightens a reporting req, compliance mandate provision: 3, and creates introduces a neutral technical change provision: 4. Program for pediatric studies of drugs Section 409I(d) of the Public Health Service Act (42 U.S.C. 284m(d)) is amended to read as follows: Of the amount made.
Key Policy Areas
Healthcare
Primary Purpose
The bill adds or tightens a reporting req, compliance mandate provision: 2, adds or tightens a reporting req, compliance mandate provision: 3, and creates introduces a neutral technical change provision: 4. Program for pediatric studies of drugs Section 409I(d) of the Public Health Service Act (42 U.S.C. 284m(d)) is amended to read as follows: Of the amount made.
Policy Domains
Sponsors
Legislative Progress
IntroducedMr. Reed (for himself and Mrs. Capito) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology